Non Small Cell Lung Cancer
Showing NaN - NaN of 41
Non Small Cell Lung Cancer, Brain Metastases Trial in Seoul (Dacomitinib)
Recruiting
- Non Small Cell Lung Cancer
- Brain Metastases
-
Seoul, Korea, Republic ofJong-Mu Sun
Jan 1, 2021
Non Small Cell Lung Cancer Trial in Gyeonggi-do, Incheon, Seoul (Olmutinib)
Terminated
- Non Small Cell Lung Cancer
-
Gyeonggi-do, Korea, Republic of
- +7 more
Aug 11, 2020
Non Small Cell Lung Cancer Trial in Worldwide (LY2603618, Pemetrexed)
Completed
- Non Small Cell Lung Cancer
-
Tucson, Arizona
- +12 more
Sep 9, 2019
Non Small Cell Lung Cancer Trial in Seoul (Olmutinib)
Completed
- Non Small Cell Lung Cancer
-
Seoul, Korea, Republic ofKonkuk University Medical Center
Aug 25, 2019
NSCLC, Non Small Cell Lung Cancer Trial in Worldwide (OSI-906, Erlotinib, Placebo)
Completed
- NSCLC
- Non Small Cell Lung Cancer
- OSI-906
- +2 more
-
La Jolla, California
- +28 more
Jan 21, 2019
Non Small Cell Lung Cancer Trial in Seoul (AZD9291)
Unknown status
- Non Small Cell Lung Cancer
-
Seoul, Korea, Republic ofDepartment of Medicine, Samsung Medical Center, Sungkyunkwan Uni
Feb 5, 2018
Non Small Cell Lung Cancer Trial in Worldwide (Vandetanib, Erlotinib)
Completed
- Non Small Cell Lung Cancer
-
Berkeley, California
- +152 more
Jan 24, 2018
Non Small Cell Lung Cancer Trial in Worldwide (Pemetrexed, Cisplatin, Etoposide)
Non Small Cell Lung Cancer Trial in Worldwide (BMS-690514, Erlotinib)
Completed
- Non Small Cell Lung Cancer
-
New Haven, Connecticut
- +29 more
Sep 23, 2015
Non Small Cell Lung Cancer Trial in Worldwide (Pemetrexed, Cisplatin, Gefitinib)
Non Small Cell Lung Cancer Trial in Worldwide (IPI 504 plus Docetaxel, Placebo plus Docetaxel)
Completed
- Non Small Cell Lung Cancer
- IPI 504 plus Docetaxel
- Placebo plus Docetaxel
-
Chandler, Arizona
- +65 more
May 16, 2014
Non Small Cell Lung Cancer Trial in Seoul (Paclitaxel/Carboplatin/Gefitinib, Paclitaxel/Carboplatin)
Completed
- Non Small Cell Lung Cancer
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 28, 2013